General Announcement::Announcement by TMC Life Sciences Bhd, 2Q FY2023 results for the period ended 31 December 2022

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
08-Feb-2023 19:07:31
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Bhd, 2Q FY2023 results for the period ended 31 December 2022
Announcement Reference
SG230208OTHRB37M
Submitted By (Co./ Ind. Name)
Foo Soon Soo
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please see attached for details.

Attachments

TMCLS Announcement_Q2 2023-Dec22-Final.pdf
Total size =273K